Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
UNICORNS IN ONCOLOGY: VALUE CREATION AND ALLOCATION
1
Zitationen
1
Autoren
2024
Jahr
Abstract
Unicorns in oncology create enormous value (over $60 billion). However, little is known about their economics. All 117 unicorns in the field of medicine and healthcare were analyzed to determine the extent to which they are oncologically significant. For the selected companies–those active in the field of oncology– location, business model, and value distribution were modeled. Twenty-two of the 117 highest-valued medical unicorns also, or predominantly, focus on oncology. With three exceptions, all are based in the USA. Their valuations range from $1.0 to $8.1 billion. By analyzing their business models further, we found eight different product/service offerings. The value added and its distribution are as follows: 60% to investors, 27% to sunk costs, 13% to management, and 1% to data providers. Oncological health tech unicorns create enormous value, but whether this value creation flows into the care system or is extracted from it is an open question.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.324 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.189 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.588 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.470 Zit.